Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Boehringer Ingelheim microParts opens inhalation device production facility

Boehringer Ingelheim microParts has opened module 2 of its new atomisation factory, a four-storey production facility at the Dortmund Technology Park, with an investment of about €70m.

Boehringer Ingelheim microParts, with its new production facility, is doubling its annual production capacity to 20 million inhalation devices (Respimat Soft Mist Inhaler).

The expansion also involves the creation of new, modern workstations, as Respimat production will require up to 150 additional employees at full capacity.

The Respimat Soft Mist Inhaler from Boehringer Ingelheim is an atomiser that delivers medication for the treatment of respiratory diseases.

Boehringer Ingelheim said that two-thirds of the investment volume was spent on the technical equipment of the building and the production systems.